Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

INDUSTRY 12OTHER 7UNKNOWN 1OTHER_GOV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1

Interventions

palbociclib 2Fulvestrant 2pembrolizumab 1niraparib 1exemestane 1Therapeutics 1Standard of Care 1Radiotherapy, Adjuvant 1Radiation 1Pharmaceutical Preparations 1Neoadjuvant Therapy 1Methods 1Letrozole 1Immunotherapy 1Aromatase Inhibitors 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Observational × exemestane × Clear all
NCT02765373 2019-05-13

Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer Patients

ChineseAMS

Unknown
500 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡